Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinoma

Activating mutations within the epidermal growth factor receptor (EGFR) identify lung adenocarcinoma patients with improved clinical responses to tyrosine kinase inhibitors gefitinib and erlotinib. By screening salivary gland carcinoma, two drug-sensitizing EGFR exon 19 delE746-A750 mutations were i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahse, R, Kosmehl, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453031/
https://www.ncbi.nlm.nih.gov/pubmed/18542074
http://dx.doi.org/10.1038/sj.bjc.6604430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453031/
https://www.ncbi.nlm.nih.gov/pubmed/18542074
http://dx.doi.org/10.1038/sj.bjc.6604430

Ejemplares similares